PT97505A - Processo para a preparacao de composicoes farmaceuticas para administracao transdermica, contendo 1-(4-etilfenil)-2-metil-3-(1-piperidinil)-1-propanona (eperisona) ou 2-metil-1-(4-metilfenil)-3-(1-piperidinil)-1-propanona (tolperisona) ou um dos seus sais, como ingrediente activo - Google Patents

Processo para a preparacao de composicoes farmaceuticas para administracao transdermica, contendo 1-(4-etilfenil)-2-metil-3-(1-piperidinil)-1-propanona (eperisona) ou 2-metil-1-(4-metilfenil)-3-(1-piperidinil)-1-propanona (tolperisona) ou um dos seus sais, como ingrediente activo

Info

Publication number
PT97505A
PT97505A PT97505A PT9750591A PT97505A PT 97505 A PT97505 A PT 97505A PT 97505 A PT97505 A PT 97505A PT 9750591 A PT9750591 A PT 9750591A PT 97505 A PT97505 A PT 97505A
Authority
PT
Portugal
Prior art keywords
piperidinyl
methyl
eperisone
tolperisone
propanean
Prior art date
Application number
PT97505A
Other languages
English (en)
Other versions
PT97505B (pt
Inventor
Masato Azuma
Tsutomu Negama
Mitsuhiro Yoshida
Hiroyuki Fujimori
Original Assignee
Eisai Co Ltd
Seikisui Chemical Co Ltd
Sansho Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd, Seikisui Chemical Co Ltd, Sansho Co filed Critical Eisai Co Ltd
Publication of PT97505A publication Critical patent/PT97505A/pt
Publication of PT97505B publication Critical patent/PT97505B/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
PT97505A 1990-04-27 1991-04-26 Processo para a preparacao de composicoes farmaceuticas para administracao transdermica, contendo 1-(4-etilfenil)-2-metil-3-(1-piperidinil)-1-propanona (eperisona) ou 2-metil-1-(4-metilfenil)-3-(1-piperidinil)-1-propanona (tolperisona) ou um dos seus sais, como ingrediente activo PT97505B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11279290 1990-04-27

Publications (2)

Publication Number Publication Date
PT97505A true PT97505A (pt) 1992-01-31
PT97505B PT97505B (pt) 1998-08-31

Family

ID=14595632

Family Applications (1)

Application Number Title Priority Date Filing Date
PT97505A PT97505B (pt) 1990-04-27 1991-04-26 Processo para a preparacao de composicoes farmaceuticas para administracao transdermica, contendo 1-(4-etilfenil)-2-metil-3-(1-piperidinil)-1-propanona (eperisona) ou 2-metil-1-(4-metilfenil)-3-(1-piperidinil)-1-propanona (tolperisona) ou um dos seus sais, como ingrediente activo

Country Status (11)

Country Link
EP (1) EP0454089B1 (pt)
JP (1) JP3170304B2 (pt)
KR (1) KR930007407B1 (pt)
CN (1) CN1049817C (pt)
AT (1) ATE109980T1 (pt)
CA (1) CA2041330C (pt)
DE (1) DE69103459T2 (pt)
DK (1) DK0454089T3 (pt)
ES (1) ES2058977T3 (pt)
MY (1) MY115126A (pt)
PT (1) PT97505B (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5252334A (en) * 1989-09-08 1993-10-12 Cygnus Therapeutic Systems Solid matrix system for transdermal drug delivery
JPH06247846A (ja) * 1993-02-22 1994-09-06 Toko Yakuhin Kogyo Kk 塩酸リトドリンの経皮吸収製剤用組成物
AU7396294A (en) † 1993-06-25 1995-01-24 Alza Corporation Incorporating poly-n-vinyl amide in a transdermal system
CN1188189C (zh) * 1995-06-07 2005-02-09 奥瑟－麦内尔制药公司 基质层含有17－脱乙酰基诺孕酯的经皮贴片及基质的用途
AT409083B (de) * 1999-04-01 2002-05-27 Sanochemia Pharmazeutika Ag Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
JP5209433B2 (ja) * 2007-10-19 2013-06-12 日東電工株式会社 貼付製剤
US20100266670A1 (en) * 2007-12-10 2010-10-21 Akira Yamamoto Transdermally absorptive preparation
JP5631854B2 (ja) * 2010-12-13 2014-11-26 久光製薬株式会社 医薬組成物および貼付剤
KR20140118410A (ko) * 2013-03-29 2014-10-08 초당약품공업 주식회사 저장 및 pH 안정성이 개선된 에페리손 의약 조성물
US10300025B2 (en) * 2016-07-27 2019-05-28 Corium, Inc. Donepezil transdermal delivery system
WO2020086046A2 (en) * 2018-10-26 2020-04-30 Sanovel Ilac Sanayi Ve Ticaret Anonim Sirketi Topical compositions comprising tolperisone and flurbiprofen combination

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL61721A (en) * 1980-12-16 1984-03-30 Blank Izhak Nitroglycerin preparations
AU563054B2 (en) * 1984-10-24 1987-06-25 Sekisui Kagaku Kogyo Kabushiki Kaisha Percutaneous tape of isdn
JPH0720866B2 (ja) * 1987-05-15 1995-03-08 三生製薬株式会社 エペリゾン又はトルペリゾン或いはそれらの塩類含有経皮適用製剤

Also Published As

Publication number Publication date
CA2041330C (en) 1996-05-28
JPH04217919A (ja) 1992-08-07
EP0454089A1 (en) 1991-10-30
PT97505B (pt) 1998-08-31
CN1056055A (zh) 1991-11-13
KR930007407B1 (ko) 1993-08-10
CN1049817C (zh) 2000-03-01
MY115126A (en) 2003-04-30
JP3170304B2 (ja) 2001-05-28
ES2058977T3 (es) 1994-11-01
DE69103459D1 (de) 1994-09-22
EP0454089B1 (en) 1994-08-17
KR910018024A (ko) 1991-11-30
DK0454089T3 (da) 1994-09-19
DE69103459T2 (de) 1995-01-19
CA2041330A1 (en) 1991-10-28
ATE109980T1 (de) 1994-09-15

Similar Documents

Publication Publication Date Title
PT97505A (pt) Processo para a preparacao de composicoes farmaceuticas para administracao transdermica, contendo 1-(4-etilfenil)-2-metil-3-(1-piperidinil)-1-propanona (eperisona) ou 2-metil-1-(4-metilfenil)-3-(1-piperidinil)-1-propanona (tolperisona) ou um dos seus sais, como ingrediente activo
AR240250A1 (es) Procedimiento para la preparacion de una nueva formualcion farmaceutica oral que contiene omeprazol como ingrediente activo.
NO963053D0 (no) Kosmetiske eller farmasöytiske preparater inneholdende mangiferin eller derivater derav
KR890700125A (ko) 신규 벤즈이미다졸 유도체, 그 제조방법 및 이 화합물을 함유하는 제약 조성물
ATE173627T1 (de) Medizinische zusammensetzung
SE8804628D0 (sv) New compounds
NO20045700L (no) Orale farmasoytiske preparater som innbefatter ionebytterharpikser med aktiv substanstilsetning og pseudoplastiske geldannende fortykningsmidler
DE69736554D1 (de) Ophthalmische arzneimittelzusammenstellung
DK122191A (da) Benzimidazolderivat og fysiologisk acceptable salte heraf samt fremgangsmaade til fremstilling af samme
BR9903282A (pt) Compostos de nitrona, um processo para a preparação dos mesmos e composições farmacêuticas que contêm os mesmos
DK701188A (da) Farmaceutiske praeparater
SE8600658D0 (sv) Novel composition of matter
ITRM910730A1 (it) Composizioni farmaceutiche, per uso topico, contenenti "scavengers" di radicali liberi dell'ossigeno e antibatterici, indicate nella terapia dei tessuti superficiali.
CA1263602A (en) Transdermal delivery of azatadine
BR9903867A (pt) Compsto de indan-1-ol, processo para seu preparo e compostos farmacêuticos contento os mesmo
TR200100055T2 (tr) Paroksetin tuzları
ES2057053T3 (es) Compuestos benzoheterociclicos.
KR910009257A (ko) 이펜프로딜 및 그의 유도체를 유효성분으로 하는 정신병치료제
DE59205998D1 (de) Arzneimittel mit antineoplastischer Wirkung enthaltend als Wirkstoff Octadecyl-[2-(N-methylpiperidino)-ethyl]-phosphat und Verfahren zu dessen Herstellung
KR980002033A (ko) 트리아졸 유도체 또는 그 염
DK1059845T3 (da) Fungicid sammensætning omfattende et benzoylphenylurinstof
GB1478817A (en) Substituted hydroxyphenyl-piperidones
ATE45090T1 (de) Pharmazeutische zusammensetzung in oralen darreichungsformen.
ATE91414T1 (de) Hustenstillende zusammensetzungen und ein verfahren zu deren herstellung.
SE8500962L (sv) Nitrodiarylsulfoxidderivat, forfarande for framstellning derav och farmaceutiska och pesticida kompositioner innehallande dem som aktiv bestandsdel

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19910916

FG3A Patent granted, date of granting

Effective date: 19980514